Intranasal Versus Intravenous Fentanyl For Procedural Analgesia in Preterm Neonates
Recruiting
Early Phase 1
Interventional Study
Procedural Pain
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- Up to 28 Days
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 75 (estimated)
- Sponsor
- Ain Shams University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Pain in neonatal life has profound long-term developmental impacts, so pain control is crucial. The intranasal (IN) route is a minimally invasive method for rapidly delivering fentanyl to provide short-term analgesia and sedation in adults and pediatrics, but few data exist about its use in neonates. Meanwhile, intravenous fentanyl is widely used in sedation and pain management.
Using intranasal …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Preterm neonates with gestational age between 28 and 36 weeks gestation.
* Undergoing painful procedures such as central venous access insertion, elective endotracheal intubation, and lumbar puncture.
Exclusion Criteria:
* known contraindications for fentanyl use, such as fe…
Contacts
Rabab Gameel Allam, MD
CONTACT